4D Molecular Therapeutics (NASDAQ:FDMT) reported quarterly losses of $(0.87) per share. This is a 210.71 percent decrease over losses of $(0.28) per share from the same period last year.
Spirit AeroSystems Makes Changes To Strengthen Operational Alignment And Program Execution
Spirit AeroSystems, Inc. (NYSE:SPR) today announced the departure of Sam Marnick, Executive Vice President and Chief Operating Officer, President, Commercial from the Company. As part of this transition, Spirit is making
